Blocking a protein that hijacks the immune system's checkpoints to allow tumor growth shows potential of an antibody-based treatment for brain cancer.
The researchers found that the protein FGL2 acted as a key "switch" to prevent tumors from being detected by the immune system and neutralized it by using anti-FGL2 antibody, curing four of the 17 infected mice.
Advertisement
"It is well-known that cancer evades immune surveillance by exploiting a series of editing mechanisms to avoid immune detection and eradication," said Shulin Li, professor at the University of Texas MD Anderson Cancer Center.
"One such mechanism is to hijack an immune cell's checkpoints, subverting the immune system and allowing tumor growth," Li noted.
FGL2 modulates the immune system's "brakes" called checkpoints, as well as immune suppressive cells that stop the immune system's natural attack on cancer cells, the findings showed.
![Revolutionary New Probe to Improve Intraop Brain Cancer Detection]( "Revolutionary New Probe to Improve Intraop Brain Cancer Detection")
Researchers at the Montreal Neurological Institute and Hospital and Polytechnique Montréal have developed a new spectroscopy probe to detect different types of brain tumors.
The study found that FGL2 increased tumor growth in mice by enhancing immune checkpoint gene expression.
The research team neutralized the protein by using an anti-FGL2 antibody.
"The average survival time in mice treated with the antibody was significantly longer than those receiving an alternative control antibody," Heimberger noted.
"Interestingly, four of 17 mice treated with FGL2 antibody were completely tumor free," Heimberger said.
The study team also found an association between levels of FGL2 expression and tumor aggressiveness. The results revealed that patients who had higher levels of FGL2 expression experienced a lower overall survival rate than patients with less FGL2 expression.
The results were published in the Journal of the National Cancer Institute.
Source: IANS
FGL2 modulates the immune system's "brakes" called checkpoints, as well as immune suppressive cells that stop the immune system's natural attack on cancer cells, the findings showed.
Revolutionary New Probe to Improve Intraop Brain Cancer Detection
Researchers at the Montreal Neurological Institute and Hospital and Polytechnique Montréal have developed a new spectroscopy probe to detect different types of brain tumors.
Advertisement
The study found that FGL2 increased tumor growth in mice by enhancing immune checkpoint gene expression.
The research team neutralized the protein by using an anti-FGL2 antibody.
"The average survival time in mice treated with the antibody was significantly longer than those receiving an alternative control antibody," Heimberger noted.
"Interestingly, four of 17 mice treated with FGL2 antibody were completely tumor free," Heimberger said.
The study team also found an association between levels of FGL2 expression and tumor aggressiveness. The results revealed that patients who had higher levels of FGL2 expression experienced a lower overall survival rate than patients with less FGL2 expression.
The results were published in the Journal of the National Cancer Institute.
Source: IANS
Australian Health Blogger Belle Gibson Admits Lying About Conquering Brain Cancer
She had claimed to have used natural therapy to cure brain cancer. Gibson became so famous that Penguin published her cookbook and Apple picked-up her app.
Advertisement
 Brain Cancer: Long-Term Use of Hormonal Contraceptives may Increase Your RiskTaking a hormonal contraceptive for at least five years is associated with a possible increase in a young woman's risk of developing a rare tumour, glioma of the brain. | Advertisement
|
Advertisement
Recommended Reading
Latest Cancer News
The mission of Axiom Space incorporated numerous experiments focusing on human stem cell aging, inflammation, and cancer within the laboratory situated in the low Earth orbit.
Providing a sustained supply of hydrogen sulfide to cancer cells, could be a remodeling strategy to improve photothermal therapy efficacy while minimizing side effects.
Colon cancer's hidden link revealed in microbiome study.
Breast cancer patients in the obese or overweight category can greatly benefit from a telephone-based weight management program in achieving significant weight loss.
A new study assessed the association of cigarette smoking and vaping on cancer-related symptom burden (fatigue, pain, emotional problems) and quality of life.